Zemuron and Apnea - a phase IV clinical study of FDA data

Summary:

Apnea is reported as a side effect among people who take Zemuron (rocuronium bromide), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Diprivan, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Apnea when taking Zemuron. It is created by eHealthMe based on reports of 872 people who have side effects when taking Zemuron from the FDA, and is updated regularly.

What is Zemuron?

Zemuron has active ingredients of rocuronium bromide. eHealthMe is studying from 873 Zemuron users. Check the latest studies of Zemuron.

What is Apnea?

Apnea (temporary absence or cessation of breathing) is found to be associated with 2,182 drugs and 2,373 conditions by eHealthMe. Check the latest studies of Apnea.

On Jun, 19, 2026

872 people reported to have side effects when taking Zemuron.
Among them, 17 people (1.95%) have Apnea.

Among these 17 people:

How long have people been on Zemuron when they have Apnea? *

What is the gender of people who have Apnea when taking Zemuron? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Apnea when taking Zemuron? *

What are other drugs people take besides Zemuron? *

What are other side effects people have besides Apnea? *

Confusional State: 6 people, 35.29%
Gastrointestinal Oedema (excessive build-up of fluid in the gastrointestinal tract tissues): 5 people, 29.41%
Gallbladder Enlargement: 5 people, 29.41%
Liver Injury: 5 people, 29.41%
Iron Overload: 5 people, 29.41%
Hyperglycemia (high blood sugar): 5 people, 29.41%
Hyperbilirubinaemia (excess of bilirubin in the blood): 5 people, 29.41%
Hepatomegaly (abnormal enlargement of the liver): 5 people, 29.41%
Hepatic Failure (liver failure): 5 people, 29.41%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 5 people, 29.41%

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 29.41%
Neuromuscular Blockade Reversal: 3 people, 17.65%
Neuromuscular Blockade: 2 people, 11.76%
Pain: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Zemuron and have Apnea?

- Check whether Apnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zemuron:

Zemuron (873 reports)

Apnea treatments and more:

Apnea (31,878 reports)

Browse all side effects of Zemuron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Apnea:

Apnea (2,182 drugs)

Browse all the conditions that are associated with Apnea:

Apnea (2,373 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rocuronium bromide (the active ingredients of Zemuron) and Zemuron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.